A leading cardiologist has cautioned that running marathons or maintaining an active lifestyle does not necessarily mean a ...

We admire grit and perseverance, but surprising research suggests that giving up on ambitions in the right way can actually ...

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.

Q: My doctor just told me that I’m now considered obese. A week ago, I wasn’t — and I haven’t gained any weight. What’s going ...

Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to ...